Prostate Cancer - Results from #25000

Limited PSA testing in indigent men in South Texas: An appropriate care or missing a prevention opportunity? - Abstract August 25, 2012

Assessment of required nodal yield in a high risk cohort undergoing extended pelvic lymphadenectomy in robotic-assisted radical prostatectomy and its impact on functional outcomes - Abstract August 24, 2012

Monitoring potential prostate cancer biomarkers in urine by capillary electrophoresis-tandem mass spectrometry - Abstract August 24, 2012

Cholesterol and prostate cancer - Abstract August 24, 2012

The impact of county-level radiation oncologist density on prostate cancer mortality in the United States - Abstract August 24, 2012

Vanderbilt-led study reveals racial disparities in prostate cancer care August 24, 2012

Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapy - Abstract August 24, 2012

Causes of death after radical prostatectomy at a large tertiary center - Abstract August 24, 2012

Location and pathological characteristics of cancers in radical prostatectomy specimens identified by transperineal biopsy compared to transrectal biopsy - Abstract August 24, 2012

Diffusion-weighted imaging of local recurrent prostate cancer after radiation therapy: Comparison with 22-core three-dimensional prostate mapping biopsy - Abstract August 24, 2012

Association between family history of prostate cancer and positive biopsies in a Brazilian screening program - Abstract August 24, 2012

Influence of high-definition multileaf collimator for three-dimensional conformal radiotherapy and intensity-modulated radiotherapy of prostate cancer - Abstract August 24, 2012

External validation of the updated briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection - Abstract August 24, 2012

Unusually large numbers needed to treat for radical prostatectomy in prostate cancer patients with PSA velocity ≤ 2 ng/ml/year - Abstract August 24, 2012

Impact of total PSA, PSA doubling time and PSA velocity on detection rates of (11)C-Choline positron emission tomography in recurrent prostate cancer - Abstract August 24, 2012

Docetaxel: A review of its use for the first-line treatment of advanced castration-resistant prostate cancer - Abstract August 24, 2012

Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5α-reductase inhibitors markedly enhances the detection rate of prostate cancer - Abstract August 23, 2012

Preoperative statin therapy is not associated with biochemical recurrence after radical prostatectomy: Our experience and meta-analysis - Abstract August 23, 2012

Sex hormone-binding globulin is an independent predictor of biochemical recurrence after radical prostatectomy - Abstract August 23, 2012

Assessment of the quality of medical care among patients with early stage prostate cancer undergoing expectant management in the United States - Abstract August 23, 2012

Page 1251 of 1436